After news that a Chinese scientist altered the DNA of a baby, a new poll reveals the complicated opinions Americans hold about future use of the gene-editing tech. Other news on innovation looks at China's failure to monitor gene-edited cancer patients and experts ideas about upcoming breakthroughs.
from Kaiser Health News http://bit.ly/2F6vHUm
January 02, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Startling Rise Of Suicides In Black Teens Since 1991 Sparks Concerns About Access To Care, Failing Outreach EffortsIn 1991, 5.9% of black teenagers reported attempting suicide, but in 2017, more than 10% of of black teenagers said they had. “It’s well documented that black youth access mental health treatment less,” said Michael Lindsey, … Read More
State Highlights: Foster Children Return To Oregon Following Charges Of Abuse From Caretakers; Missouri’s Planned Parenthood Lawyers Seek Answers About License DenialMedia outlets report on news from Oregon, Missouri, New Jersey, New Hampshire, Minnesota, Ohio, North Carolina, California, Iowa, Georgia and Hawaii. from Kaiser Health News https://ift.tt/35AO9iL … Read More
Viewpoints: Plenty To Win Or Lose For Dem’s Presidential Candidates Weighing In On Health Care At Debate; Start Telling Us How ‘Medicare For All’ Would WorkOpinion writers weigh in on these health care issues and others from Kaiser Health News https://ift.tt/2owk7fK … Read More
New Estimate On House’s Proposed Drug Bill Reports Fast Savings Of $345B To Taxpayers, Big Changes To DrugmakersThe bill proposes that Medicare establish prices based on a price index on other nation's sales. News on the industry looks at how Canada's transparency on drug trials differs from the U.S., as well. from Kaiser Health News … Read More
California Governor’s Bill-Signing Marathon Offers Glimpse Of 2020 IssuesGov. Gavin Newsom wrapped up his bill-signing marathon Sunday, capping the end of a legislative session that will have a big impact on Californians’ health care and coverage. Some of the most high-profile — and contentious — … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment